These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26312014)
1. mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel. Huang TQ; Zou MX; Pasek DA; Meissner G J Receptor Ligand Channel Res; 2015; 8():43-51. PubMed ID: 26312014 [TBL] [Abstract][Full Text] [Related]
2. Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. Yamaguchi N; Chakraborty A; Pasek DA; Molkentin JD; Meissner G Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2187-95. PubMed ID: 21421818 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor. Chakraborty A; Pasek DA; Huang TQ; Gomez AC; Yamaguchi N; Anderson ME; Meissner G PLoS One; 2014; 9(8):e104338. PubMed ID: 25093823 [TBL] [Abstract][Full Text] [Related]
4. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1. Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671 [TBL] [Abstract][Full Text] [Related]
5. IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor. Huang TQ; Willis MS; Meissner G JAKSTAT; 2015; 4(4):e1158379. PubMed ID: 27217982 [TBL] [Abstract][Full Text] [Related]
6. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. Yamaguchi N; Takahashi N; Xu L; Smithies O; Meissner G J Clin Invest; 2007 May; 117(5):1344-53. PubMed ID: 17431507 [TBL] [Abstract][Full Text] [Related]
7. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
8. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
9. Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2. Lavorato M; Huang TQ; Iyer VR; Perni S; Meissner G; Franzini-Armstrong C J Muscle Res Cell Motil; 2015 Apr; 36(2):205-14. PubMed ID: 25694159 [TBL] [Abstract][Full Text] [Related]
10. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Xiao B; Zhong G; Obayashi M; Yang D; Chen K; Walsh MP; Shimoni Y; Cheng H; Ter Keurs H; Chen SR Biochem J; 2006 May; 396(1):7-16. PubMed ID: 16483256 [TBL] [Abstract][Full Text] [Related]
11. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation. Galbaugh T; Cerrito MG; Jose CC; Cutler ML BMC Cell Biol; 2006 Sep; 7():34. PubMed ID: 16984645 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1. Phin S; Kupferwasser D; Lam J; Lee-Fruman KK Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446 [TBL] [Abstract][Full Text] [Related]
13. Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. Tian X; Tang Y; Liu Y; Wang R; Chen SR Biochem J; 2013 Nov; 455(3):367-75. PubMed ID: 23992453 [TBL] [Abstract][Full Text] [Related]
14. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides. Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026 [TBL] [Abstract][Full Text] [Related]
17. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Hales EC; Taub JW; Matherly LH Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475 [TBL] [Abstract][Full Text] [Related]
18. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Currie S; Loughrey CM; Craig MA; Smith GL Biochem J; 2004 Jan; 377(Pt 2):357-66. PubMed ID: 14556649 [TBL] [Abstract][Full Text] [Related]
19. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [TBL] [Abstract][Full Text] [Related]
20. Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration. Qiu Q; Yang M; Tsang BK; Gruslin A Mol Hum Reprod; 2004 Sep; 10(9):677-84. PubMed ID: 15235105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]